GB9826180D0 - Novel process - Google Patents
Novel processInfo
- Publication number
- GB9826180D0 GB9826180D0 GBGB9826180.3A GB9826180A GB9826180D0 GB 9826180 D0 GB9826180 D0 GB 9826180D0 GB 9826180 A GB9826180 A GB 9826180A GB 9826180 D0 GB9826180 D0 GB 9826180D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel process
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9826180.3A GB9826180D0 (en) | 1998-11-30 | 1998-11-30 | Novel process |
EP99973026A EP1135382A1 (en) | 1998-11-30 | 1999-11-30 | Method of producing paroxetine hydrochloride |
PCT/GB1999/003992 WO2000032593A1 (en) | 1998-11-30 | 1999-11-30 | Method of producing paroxetine hydrochloride |
AU13978/00A AU1397800A (en) | 1998-11-30 | 1999-11-30 | Method of producing paroxetine hydrochloride |
JP2000585235A JP2002531451A (en) | 1998-11-30 | 1999-11-30 | Preparation of paroxetine hydrochloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9826180.3A GB9826180D0 (en) | 1998-11-30 | 1998-11-30 | Novel process |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9826180D0 true GB9826180D0 (en) | 1999-01-20 |
Family
ID=10843292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9826180.3A Ceased GB9826180D0 (en) | 1998-11-30 | 1998-11-30 | Novel process |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1135382A1 (en) |
JP (1) | JP2002531451A (en) |
AU (1) | AU1397800A (en) |
GB (1) | GB9826180D0 (en) |
WO (1) | WO2000032593A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923446D0 (en) * | 1999-10-04 | 1999-12-08 | Smithkline Beecham Plc | Novel process |
IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
US7396542B2 (en) | 2001-12-28 | 2008-07-08 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
CA2496726A1 (en) | 2002-09-19 | 2004-04-01 | Sumitomo Chemical Company, Limited | Methods of crystal precipitation |
MY140618A (en) | 2003-02-28 | 2009-12-31 | Kowa Co | Method for preparing acid addition salts of polyacidic basic compounds |
ATE407933T1 (en) * | 2005-05-26 | 2008-09-15 | Apotecnia S A | METHOD FOR PRODUCING PAROXETINE HYDROCHLORIDE HEMIHYDRATE |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3688827T2 (en) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidine derivative, its manufacture and its use as a medicine. |
SK283608B6 (en) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | New forms of parotexin hydrochloride |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
-
1998
- 1998-11-30 GB GBGB9826180.3A patent/GB9826180D0/en not_active Ceased
-
1999
- 1999-11-30 JP JP2000585235A patent/JP2002531451A/en active Pending
- 1999-11-30 WO PCT/GB1999/003992 patent/WO2000032593A1/en not_active Application Discontinuation
- 1999-11-30 AU AU13978/00A patent/AU1397800A/en not_active Abandoned
- 1999-11-30 EP EP99973026A patent/EP1135382A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1135382A1 (en) | 2001-09-26 |
AU1397800A (en) | 2000-06-19 |
WO2000032593A1 (en) | 2000-06-08 |
JP2002531451A (en) | 2002-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0106312D0 (en) | Process | |
GB9816385D0 (en) | Process | |
EP1127060A4 (en) | Hydroboronation process | |
GB9827387D0 (en) | Novel process | |
GB9826180D0 (en) | Novel process | |
GB9826242D0 (en) | Novel process | |
GB9806527D0 (en) | Process | |
GB9816564D0 (en) | Process | |
GB9824298D0 (en) | Novel process | |
GB9826175D0 (en) | Novel process | |
GB9826178D0 (en) | Novel process | |
GB9817195D0 (en) | Novel process | |
GB9806786D0 (en) | Novel process | |
GB9828779D0 (en) | Novel process | |
GB9828767D0 (en) | Novel process | |
GB9828780D0 (en) | Novel process | |
GB9807834D0 (en) | Novel process | |
GB9826176D0 (en) | Novel process | |
GB9812016D0 (en) | Novel process | |
GB9817159D0 (en) | Novel process | |
GB9813269D0 (en) | Novel process | |
GB9817196D0 (en) | Novel process | |
GB9821596D0 (en) | Novel process | |
GB9826182D0 (en) | Novel process | |
GB9822164D0 (en) | Novel process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |